Clearwater has advised the shareholders of Controlled Polymers, a specialty compounds and masterbatches producer, on its sale to Americhem, a US-based innovative, technology-driven leader in the global polymer industry. The deal sees private equity firm Blue Equity and investment company Chrispa successfully exit their investment.
For more than 30 years, Controlled Polymers has developed a specialised portfolio of products integral to many medical device and healthcare applications, including a world leading position in the hearing aid industry. The company places great importance on sustainability and strives to produce the greenest compounds in the world through four key areas: responsible sourcing, responsible energy-efficient production, research and development focused on sustainability, and customer workshops to inspire ideas for sustainable solutions.
Americhem is an innovative, technology-driven leader in the global polymer industry. Americhem operates 11 manufacturing plants and maintains sales offices throughout the world.
Through the acquisition of Controlled Polymers, Americhem will expand its global reach with increased product offerings, extended service capabilities, and broadened technical expertise. Controlled Polymers’ expertise within medical compounds and masterbatches gained in close collaboration with its strategic customer partnerships can, together with Americhem, be expanded to an even larger global healthcare customer base.
